Democratic Republic of the Congo (the)

in page functions
[French]
Congo Democratic Republic of the
Total population (2017) 82,242,537
Birth cohort (2017) 3,351,364
Surviving Infants (surviving to 1 year per year, 2017) 3,127,787
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 75/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 98/1000
World Bank Index, IDA (2015) 3.00
Gross Nation Income (per capita US$, 2015) 410
Co-financing group (2018) Initial self-financing
No. of districts/territories (2016) 518

Contact Gavi

For more info, contact Gavi country representative officer or email here

Gavi support for Congo Democratic Republic of the

Type of support

Approvals

2001-2022 (US$)
(29 May 2018)

Commitments

2001-2022 (US$)
(29 May 2018)

Disbursements

2000-2018 (US$)
(29 May 2018)

% Disbursed

(29 May 2018)
2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020
Total $780,271,335 $892,867,048 $771,880,535
Civil Society Organisation support (CSO) $9,767,601 $9,767,601 $9,857,132 101%
Cold Chain Equipment Optimisation Platform (CCEOP) $22,379,004 $22,379,004 $12,612,670 56%
Health system strengthening (HSS 1) $55,814,000 $55,814,000 $55,759,817 100%
Health system strengthening (HSS 2) $111,302,940 $144,991,152 $102,879,805 92%
Immunisation services support (ISS) $25,807,280 $25,807,280 $25,807,280 100%
Injection Safety Devices (NVS) $2,263,179 $3,483,179 $2,532,098 112%
Injection safety support (INS) $2,713,931 $2,713,931 $2,713,931 100%
IPV (NVS) $13,209,727 $13,209,727 $12,132,356 92%
Measles SIA (NVS) $11,710,012 $11,710,012 $11,710,012 100%
Measles SIA - Operational costs (OPC) $20,274,500 $20,274,500 $19,872,616 98%
Meningitis A - campaign (NVS) $13,744,023 $13,744,023 $13,744,023 100%
Meningitis A - operational costs (OPC) $11,645,500 $11,645,500 $11,645,500 100%
Penta (NVS) $171,122,129 $176,705,129 $172,520,023 101%
Pneumo (NVS) $243,341,988 $280,538,488 $257,445,248 106%
Product Switch Grant (PSG) $823,513 $823,513 $823,513 100%
Rotavirus (NVS) $8,742,000 $39,946,000 $4,760,514 54%
Tetra DTP-HepB (NVS) $10,357,601 $10,357,601 $10,357,601 100%
Vaccine Introduction Grant (VIG) $8,184,467 $8,184,467 $6,592,615 81%
Yellow Fever (NVS) $37,067,940 $40,771,940 $38,113,781 103%

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Congo Democratic Republic of the DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2016)

Grade of confidence


N/A
DTP3 - Official country estimates (2016) 92%
M:F sex ratio at birth (2017) 1.03
Household survey: DTP3 coverage for male (2012) 60.00%
Household survey: DTP3 coverage for female (2012) 61.10%
Household survey: Last DTP3 survey (2012) 61%
% districts achieving > 80% DTP3 coverage (2016) 83%
% districts achieving < 50% DTP3 coverage (2016) 1%
MCV WHO/UNICEF estimates (2016) 77%

Breakdown of support

Non-vaccine support Vaccine support
32% 68%
$248,564,879 $523,315,656

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Congo Democratic Republic of the

07 June 2018

IPV DRC 2015

Gavi Board approves funding for inactivated poliovirus vaccine until 2020

Flexible support to Nigeria and post-transition countries also approved.

21 May 2018

Ebola DRC first shots prepared

Ebola vaccine to help tackle DRC outbreak

Vaccination begins in the Democratic Republic of the Congo.

19 May 2018

Ebola Q&A thumb

DR Congo Ebola outbreak response: Q&A with Gavi CEO Dr Seth Berkley

Gavi CEO Dr Seth Berkley answers questions about the planned deployment of Merck’s rVSV-ZEBOV vaccine to counter the ongoing Ebola outbreak in the north west of the Democratic Republic of the Congo (DRC).

close icon

modal window here